Prognostic value of the aggregate index of systemic inflammation and controlling nutritional status score for all-cause mortality in patients undergoing maintenance hemodialysis: a retrospective cohort study - Scorecard - MDSpire

Prognostic value of the aggregate index of systemic inflammation and controlling nutritional status score for all-cause mortality in patients undergoing maintenance hemodialysis: a retrospective cohort study

  • By

  • Haitao Bai

  • Shuang Cheng

  • Dan Lv

  • Yilan Liang

  • Wenli Chen

  • June 18, 2026

  • 0 min

Share

Clinical Scorecard: Prognostic Significance of the Aggregate Index of Systemic Inflammation and Controlling Nutritional Status Score for All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: A Retrospective Cohort Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsAggregate Index of Systemic Inflammation (AISI) and Controlling Nutritional Status (CONUT) score, both of which are critical for assessing patient risk and guiding interventions.
Target Population
Care Setting

Key Highlights

  • Clarify the role of CVC utilization and elevated AST levels in increasing five-year all-cause mortality.

Guideline-Based Recommendations

Diagnosis

    Management

    • Implement targeted interventions based on AISI and CONUT score findings, such as nutritional supplementation and anti-inflammatory therapies.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients undergoing maintenance hemodialysis

        Focus on addressing malnutrition and systemic inflammation to improve outcomes.

        Clinical Best Practices

        • Develop protocols for routine AISI and CONUT score assessments, including training for clinical staff on interpretation and application.

        Related Resources & Content

          Original Source(s)

          Prognostic value of the aggregate index of systemic inflammation and controlling nutritional status score for all-cause mortality in patients undergoing maintenance hemodialysis: a retrospective cohort study

          • by Haitao Bai, Shuang Cheng, Dan Lv, Yilan Liang, Wenli Chen

          • June 18, 2026

          Related Content

          Peptides Are Outrunning the Rulebook

          A new JAMA Viewpoint argues US drug policy is built for a market that no longer behaves like one.

          Editorial: Immunosenescence and inflammaging: modulating immune function through diet, lifestyle, and therapeutic interventions

          The role of the bidirectional regulatory network between immune cells and stromal cells in cardiac repair and fibrosis following myocardial infarction